Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 607

The DOI matches its Crossref record.

Treatment of Hereditary Angioedema with Danazol: Reversal of Clinical and Biochemical Abnormalities

Gelfand, Jeffrey A., Sherins, Richard J., Alling, David W., Frank, Michael M.·1976·New England Journal of Medicine

Abstract

Danazol, an androgen derivative, was evaluated for its effectiveness in preventing attacks of hereditary angioedema in a double-blind study with nine patients. Of 47 placebo courses, 44 ended with attacks, but during 46 danazol courses only one attack occurred. Side effects were minimal, and virilization was not observed in the women studied. C1 esterase inhibitor levels increased three to four times, and levels of the fourth component of complement (C4) increased 15 times. These changes began during the first day of therapy and were maximal by one to two weeks. After therapy was stopped, C1 esterase inhibitor and C4 levels rapidly decreased. Danazol effectively prevents attacks in hereditary angioedema and acts to correct the underlying biochemical abnormality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm197612232952602

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 607

Metadata

Authors
Gelfand, J. A., Sherins, R. J., Alling, D. W., & Frank, M. M.
Venue
New England Journal of Medicine
Published
1976-12-23
Volume
295
Issue
26
Pages
1444-1448
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2004395480
Cited by
607
References
0
FWCI
15.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of Hereditary Angioedema with Danazol: Reversal of Clinical and Biochemical Abnormalities. https://app.cochat.ai/papers/10.1056/nejm197612232952602
The paper
Gelfand, J. A., Sherins, R. J., Alling, D. W., & Frank, M. M. (1976). Treatment of Hereditary Angioedema with Danazol: Reversal of Clinical and Biochemical Abnormalities. New England Journal of Medicine. https://doi.org/10.1056/nejm197612232952602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.